BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Selimovic D, El-Khattouti A, Ghozlan H, Haikel Y, Abdelkader O, Hassan M. Hepatitis C virus-related hepatocellular carcinoma: An insight into molecular mechanisms and therapeutic strategies. World J Hepatol 2012; 4(12): 342-355 [PMID: 23355912 DOI: 10.4254/wjh.v4.i12.342]
URL: https://www.wjgnet.com/1948-5182/full/v4/i12/342.htm
Number Citing Articles
1
Maria Lina Tornesello, Luigi Buonaguro, Francesco Izzo, Franco M. Buonaguro. Molecular alterations in hepatocellular carcinoma associated with hepatitis B and hepatitis C infectionsOncotarget 2016; 7(18): 25087 doi: 10.18632/oncotarget.7837
2
Javeria Khalid, Mohammad Umar, Tofeeq Ur-Rehman, Mashhood Ali, Gul Majid Khan. Tumor aggression among hepatitis-C related hepatocellular carcinoma patients: an observational study regarding the impact of anti-HCV therapyInfectious Agents and Cancer 2020; 15(1) doi: 10.1186/s13027-020-00300-z
3
O. V. Masalova, E. I. Lesnova, E. I. Samokhvalov, K. Yu. Permyakova, A. V. Ivanov, S. N. Kochetkov, A. A. Kushch. Low-molecular-weight regulators of biogenic polyamine metabolism affect cytokine production and expression of hepatitis С virus proteins in Huh7.5 human hepatocarcinoma cellsMolecular Biology 2017; 51(3): 453 doi: 10.1134/S0026893317030128
4
Gianni Testino, Paolo Borro. Chemoprevention of hepatocellular carcinoma in patients with hepatitis C virus related cirrhosisWorld Journal of Hepatology 2013; 5(10): 521-527 doi: 10.4254/wjh.v5.i10.521
5
Bin Han, Hadas Dvory-Sobol, Andrew Greenstein, Joseph F. McCarville, Magdeleine Hung, Xiaohong Liu, Michael D. Miller, Hongmei Mo. Development and application of a fast, reproducible assay to measure HCV NS3 protease activity using Escherichia coli lysateJournal of Virological Methods 2015; 225: 76 doi: 10.1016/j.jviromet.2015.09.002
6
Vivek Chavda, Kelsee K. Zajac, Jenna Lynn Gunn, Pankti Balar, Avinash Khadela, Dixa Vaghela, Shruti Soni, Charles R. Ashby, Amit K. Tiwari. Ethnic differences in hepatocellular carcinoma prevalence and therapeutic outcomesCancer Reports 2023; 6(S1) doi: 10.1002/cnr2.1821
7
Mario Capasso, Valentina Cossiga, Maria Guarino, Luisa Ranieri, Filomena Morisco. The Role of Hepatitis Viruses as Drivers of HepatocancerogenesisCancers 2024; 16(8): 1505 doi: 10.3390/cancers16081505
8
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract2017; : 2931 doi: 10.1007/978-3-319-26956-6_164
9
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract2016; : 1 doi: 10.1007/978-3-319-26587-2_164-1
10
Linda Galasso, Lucia Cerrito, Valeria Maccauro, Fabrizio Termite, Irene Mignini, Giorgio Esposto, Raffaele Borriello, Maria Elena Ainora, Antonio Gasbarrini, Maria Assunta Zocco. Inflammatory Response in the Pathogenesis and Treatment of Hepatocellular Carcinoma: A Double-Edged WeaponInternational Journal of Molecular Sciences 2024; 25(13): 7191 doi: 10.3390/ijms25137191
11
Maria C Sorbo, Luca Carioti, Maria C Bellocchi, FrancescoPaolo Antonucci, Daniele Sforza, Ilaria Lenci, Matteo Ciancio Manuelli, Daniele Armenia, Francesco De Leonardis, Martina Milana, Tommaso M Manzia, Mario Angelico, Giuseppe Tisone, Valeria Cento, Carlo F Perno, Francesca Ceccherini‐Silberstein. HCV resistance compartmentalization within tumoral and non‐tumoral liver in transplanted patients with hepatocellular carcinomaLiver International 2019; 39(10): 1986 doi: 10.1111/liv.14168
12
Hélène Dubois‐Pot‐Schneider, Karim Fekir, Cédric Coulouarn, Denise Glaise, Caroline Aninat, Kathleen Jarnouen, Rémy Le Guével, Takashi Kubo, Seiichi Ishida, Fabrice Morel, Anne Corlu. Inflammatory cytokines promote the retrodifferentiation of tumor‐derived hepatocyte‐like cells to progenitor cellsHepatology 2014; 60(6): 2077 doi: 10.1002/hep.27353
13
Devis Pascut, Minh Hoang, Nhu N. Q. Nguyen, Muhammad Yogi Pratama, Claudio Tiribelli. HCV Proteins Modulate the Host Cell miRNA Expression Contributing to Hepatitis C Pathogenesis and Hepatocellular Carcinoma DevelopmentCancers 2021; 13(10): 2485 doi: 10.3390/cancers13102485
14
Trang H. Au, Christopher J. Destache, Renuga Vivekanandan. Hepatitis C therapy: Looking toward interferon-sparing regimensJournal of the American Pharmacists Association 2015; 55(2): e72 doi: 10.1331/JAPhA.2015.15508
15
Jing Qin Wu, Monica Miranda Saksena, Vincent Soriano, Eugenia Vispo, Nitin K Saksena. Differential regulation of cytotoxicity pathway discriminating between HIV, HCV mono- and co-infection identified by transcriptome profiling of PBMCsVirology Journal 2015; 12(1) doi: 10.1186/s12985-014-0236-6
16
Ivan Schietroma, Giuseppe Corano Scheri, Claudia Pinacchio, Maura Statzu, Arnolfo Petruzziello, Vincenzo Vullo. Hepatitis C Virus and Hepatocellular Carcinoma: Pathogenetic Mechanisms and Impact of Direct-Acting AntiviralsThe Open Virology Journal 2018; 12(1): 16 doi: 10.2174/1874357901812010016
17
Mohammad Irshad, Priyanka Gupta, Khushboo Irshad. Molecular basis of hepatocellular carcinoma induced by hepatitis C virus infectionWorld Journal of Hepatology 2017; 9(36): 1305-1314 doi: 10.4254/wjh.v9.i36.1305
18
Norica Branza-Nichita, Catalina Petrareanu, Catalin Lazar, Izabela Sokolowska, Costel C. Darie. Advancements of Mass Spectrometry in Biomedical ResearchAdvances in Experimental Medicine and Biology 2014; 806: 453 doi: 10.1007/978-3-319-06068-2_22
19
Elham Shirvani-Dastgerdi, Robert E Schwartz, Alexander Ploss. Hepatocarcinogenesis associated with hepatitis B, delta and C virusesCurrent Opinion in Virology 2016; 20: 1 doi: 10.1016/j.coviro.2016.07.009
20
Aqsa Ikram, Bisma Rauff, Badr Alzahrani, Faryal Mehwish Awan, Ayesha Obaid, Anam Naz, Salik Javed Kakar, Hussnain Ahmed Janjua. Integrated analysis to study the interplay between post-translational modifications (PTM) in hepatitis C virus proteins and hepatocellular carcinoma (HCC) developmentScientific Reports 2022; 12(1) doi: 10.1038/s41598-022-19854-6
21
Ramareddy V. Guntaka, Mythili K. Padala. Interaction of Hepatitis C Viral Proteins with Cellular Oncoproteins in the Induction of Liver CancerISRN Virology 2014; 2014: 1 doi: 10.1155/2014/351407
22
Ikram Sghaier, Etienne Brochot, Besma Y. Loueslati, Wassim Y. Almawi. Hepatitis C virus protein interaction network for HCV clearance and association of DAA to HCC occurrence via data mining approach: A systematic review and critical analysisReviews in Medical Virology 2019; 29(2) doi: 10.1002/rmv.2033
23
Mariantonietta Pisaturo, Alessandra Di Fraia, Laura Occhiello, Carmine Minichini, Mario Starace, Valentina Iodice, Nunzia Farella, Maria Stanzione, Nicola Coppola. Genetic Variability in Patients with HCV-Related Hepatocellular CarcinomaInfection and Drug Resistance 2021; : 5199 doi: 10.2147/IDR.S337647
24
Waqar Abd Al Qahar Al-Kubaisy, Kadhim Jawad Obaid, Nor Aini Mohd Noor, Nik Shamsidah Binti Nik Ibrahim, Ahmed Albu-Kareem Al-Azawi. Hepatitis C Virus Prevalence and Genotyping among Hepatocellular Carcinoma Patients in BaghdadAsian Pacific Journal of Cancer Prevention 2014; 15(18): 7725 doi: 10.7314/APJCP.2014.15.18.7725
25
O. V. Masalova, E. I. Lesnova, K. Yu. Permyakova, E. I. Samokhvalov, A. V. Ivanov, S. N. Kochetkov, A. A. Kushch. Effect of Hepatitis C virus proteins on the production of proinflammatory and profibrotic cytokines in Huh7.5 human hepatoma cellsMolecular Biology 2016; 50(3): 422 doi: 10.1134/S0026893316020163
26
Maria Lina Tornesello, Luigi Buonaguro, Fabiana Tatangelo, Gerardo Botti, Francesco Izzo, Franco M. Buonaguro. Mutations in TP53, CTNNB1 and PIK3CA genes in hepatocellular carcinoma associated with hepatitis B and hepatitis C virus infectionsGenomics 2013; 102(2): 74 doi: 10.1016/j.ygeno.2013.04.001
27
Maximilian Bunz, Mona Eisele, Dan Hu, Michael Ritter, Julia Kammerloher, Sandra Lampl, Michael Schindler. CD81 suppresses NF-κB signaling and is downregulated in hepatitis C virus expressing cellsFrontiers in Cellular and Infection Microbiology 2024; 14 doi: 10.3389/fcimb.2024.1338606